Skip to main content

Advertisement

SpringerLink
Log in

Abatacept and serious respiratory infections in patients with previous lung disease

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Abatacept is a biologic agent used in the treatment of rheumatoid arthritis, for which underlying chronic obstructive lung disease is listed as a precaution to its use due to concern for increased risk of respiratory adverse events. We describe two cases of severe respiratory complications affecting rheumatoid arthritis patients undergoing treatment with abatacept who had been previously diagnosed with underlying lung disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Choy E, Panayi G (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Eng J Med 344:907–916

    Article  CAS  Google Scholar 

  2. Weinblatt M, Combe B, Covucci A et al (2006) Safety of the selective costimulation modulator abacept in rheumatoid arthritis patients receiving background biologic and non biologic disease-modifying antirheumatic drugs. Arthritis Rheum 54:2807–2816

    Article  PubMed  CAS  Google Scholar 

  3. Kremer J, Dougados M, Emery P et al (2005) Treatment of rheumatoid arthritis with the seclective costimulation modulator abacept: twelve month results of a phase IIb double blind randomized, placebo-controlled trial. Arthritis Rheum 52:2263–2271

    Article  PubMed  CAS  Google Scholar 

  4. Genovese M, Becker J, Schiff M et al (2005) Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. N Eng J Med 353(21):1114–1123

    Article  CAS  Google Scholar 

  5. Cannon GW (1997) Methotrexate pulmonary toxicity. Rheum Dis Clin North Am 23(4):917–937

    Article  PubMed  CAS  Google Scholar 

  6. Parry S, Barbatzas C et al (2002) Sulphasalazine and lung toxicity. Eur Respir J 19(4):756–764

    Article  PubMed  CAS  Google Scholar 

  7. Ananthakrishnan AN, Attila T et al (2007) Severe pulmonary toxicity after azathiprine/6-mercaptopurine initiation for the treatment of inflammatory bowel disease. J Clin Gastroenterol 41(7):682–688

    Article  PubMed  CAS  Google Scholar 

  8. Zimmer C, Beiderlinden M et al (2006) Lethal acute respiratory distress syndrome during anti-TNF-α therapy for rheumatoid arthritis. Clin Rheumatol 25:430–432

    Article  PubMed  Google Scholar 

  9. Dixon WG, Watson K et al (2006) Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy. Arthritis Rheum 54:2368–2376

    Article  PubMed  CAS  Google Scholar 

  10. Blake GH, Abell TD et al (1988) Cigarette smoking and upper respiratory infection among recruits in basic combat training. Ann Intern Med 109:198–202

    PubMed  CAS  Google Scholar 

  11. Willemse BWM, ten Hacken NHT et al (2005) Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur Respir J 26:835–845

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

None.

Author information

Authors and Affiliations

  1. Division of Rheumatology, The University of Utah, 4B200 School of Medicine, 30 North 1900 East, Salt Lake City, UT, 84132-2404, USA

    Karla L. Miller & Allen D. Sawitzke

  2. Department of Internal Medicine, The University of Utah, 4C104 School of Medicine, 30 North 1900 East, Salt Lake City, UT, 84132, USA

    John Doane

Authors
  1. Karla L. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Allen D. Sawitzke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John Doane
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karla L. Miller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miller, K.L., Sawitzke, A.D. & Doane, J. Abatacept and serious respiratory infections in patients with previous lung disease. Clin Rheumatol 27, 1569–1571 (2008). https://doi.org/10.1007/s10067-008-0979-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-008-0979-9

Keywords

Search

Navigation